Multiplex molecular diagnostic test for simultaneous detection of SARS-CoV-2, influenza, and respiratory syncytial virus. Provides rapid and precise results using biochip-based technology.
Manufactured by
Genesystem Co., Ltd.
Daejeon, South Korea
Where Precision Meets Convenience : Inspiring Point-of-Care Molecular Diagnostics Genesystem is a biotech engineering company from South Korea specializing in molecular diagnostic solutions to target point-of-care testing applications. Genesystem develops and markets state-of-the-art diagnostic platforms for precise and convenient tests using its unique biochip technology.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Operon S.A.
Spain · 4 relevant products
Goldsite Diagnostics Inc.
China · 2 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
62 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 119 closest product alternatives
Operon S.A. · Spain
A molecular diagnostic test for the simultaneous detection of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus in human samples. Used for in vitro diagnosis of respiratory infections.
Goldsite Diagnostics Inc. · China
Multiplex antigen test simultaneously detecting SARS-CoV-2, Influenza A/B, and RSV from a single patient sample. Enables rapid point-of-care diagnosis of common respiratory pathogens for clinical and emergency settings.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
116 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products